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Abstract
The effects of rickets on children recovery from severe acute malnutrition (SAM) are unknown.
Rickets may affect both growth and susceptibility to infectious diseases. We investigated the
associations of clinically diagnosed rickets with life‐threatening events and anthropometric
recovery during 1 year following inpatient treatment for complicated SAM. This was a secondary
analysis of clinical trial data among non‐human immunodeficiency virus‐infected Kenyan children
with complicated SAM (2–59 months) followed for 1 year posthospital discharge (ClinicalTrials.
gov ID NCT00934492). The outcomes were mortality, hospital readmissions, and growth during
12 months. The main exposure was clinically diagnosed rickets at baseline. Of 1,778 children
recruited, 230 (12.9%, 95% CI [11.4, 14 .6]) had clinical signs of rickets at baseline. Enrolment
at an urban site, height‐for‐age and head circumference‐for‐age z scores were associated with
rickets. Rickets at study enrolment was associated with increased mortality (adjusted Hazard
Ratio [aHR] 1.61, 95% CI [1.14, 2.27]), any readmission (aHR 1.37, 95% CI [1.09. 1.72]),
readmission for severe pneumonia (aHR 1.37, 95% CI [1.05, 1.79]), but not readmission with
diarrhoea (aHR 1.05, 95% CI [0.73, 1.51]). Rickets was associated with increased height gain
(centimetres), adjusted regression coefficient 0.19 (95% CI [0.10, 0.28]), but not changes in head
circumference, mid‐upper arm circumference, or weight. Rickets was common among children
with SAM at urban sites and associated with increased risks of severe pneumonia and death.
Increased height gain may have resulted from vitamin D and calcium treatment. Future work
should explore possibility of other concurrent micronutrient deficiencies and optimal treatment
of rickets in this high‐risk population.
KEYWORDS
children, mortality, rickets, severe acute malnutrition, severe pneumonia
1 | BACKGROUND
Rickets in children is a disease characterized by inadequate or
defective bone mineralization and disruption of growth plates caused
by deficiency of vitamin D or calcium or impaired metabolism of
phosphate (Munns et al., 2016; Razali, Hwu, & Thilakavathy, 2015). It
manifests as skeletal abnormalities, including bowed legs, widening
wrist, craniotabes (abnormal softening of skull), rachitic rosary
(enlarged costochondral junctions of ribs resembling rosary beads),
and frontal bossing (prominent forehead; Fukumoto et al., 2015). In
developed countries, rickets appears to be re‐emerging after decades
of low prevalence (Robinson et al., 2006). Rickets is often considered
a rare disease in tropical regions because of the role of sunlight in
synthesis of vitamin D (Lerch & Meissner, 2007). However, there is
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evidence it is prevalent in countries with abundant sunlight (Al‐Atawi,
Al‐Alwan, Al‐Mutair, Tamim, & Al‐Jurayyan, 2009; Bener & Hoffmann,
2010; Jones et al., 2017; Ozkan, 2010; Wondale, Shiferaw, & Lulseged,
2005). In Kenya, rickets is common in the urban informal settlements
of Nairobi and is predominantly caused by vitamin D deficiency
(Edwards et al., 2014; Jones et al., 2017).
Apart from its role in bone mineralization, vitamin D plays a vital
role in regulating immune responses to infection (Chun, Adams, &
Hewison, 2011; Lang & Aspinall, 2017; Rosen, Daich, Soliman,
Brathwaite, & Shoenfeld, 2016). Available evidence suggests an associ-
ation between vitamin D deficiency and risk of pneumonia, acute
lower respiratory tract infections, and diarrhoea among children and
mortality among adults (Haider, Nagi, & Khan, 2010; Holter et al.,
2016; Muhe, Lulseged, Mason, & Simoes, 1997; Thornton, Marin,
Mora‐Plazas, & Villamor, 2013; Wayse, Yousafzai, Mogale, & Filteau,
2004). Among children, vitamin D deficiency is associated with growth
retardation (Ganmaa et al., 2017). However, there is unclear evidence
from interventional trials of vitamin D supplementation concerning
reduction of risks of pneumonia, diarrhoea, malaria, hospital readmis-
sion, or alterations in growth (Manaseki‐Holland et al., 2012; Smyth
& Broderick, 1997; Sudfeld et al., 2017; Yakoob, Salam, Khan, &
Bhutta, 2016).
Children with complicated severe acute malnutrition (SAM) remain
susceptible to serious infections during recovery (Berkley et al., 2016),
and to our knowledge, no study has evaluated the effect of the pres-
ence of rickets on their recovery. In this study, we aimed to investigate
the associations of clinically diagnosed rickets at study enrolment with
anthropometric recovery and life‐threatening events during 1 year
following inpatient treatment for complicated SAM.
2 | METHODS AND MATERIALS
2.1 | Study design
This was a secondary analysis of data from a double blind randomized
controlled clinical trial. Data from both the intervention and placebo
arms were included in this secondary analysis. The parent trial investi-
gated the efficacy of daily co‐trimoxazole prophylaxis in reducing
1 year postdischarge mortality among severely malnourished children
without human immunodeficiency virus (HIV) infection admitted to
four hospitals in Kenya (ClinicalTrials.gov ID NCT00934492), as
detailed elsewhere (Berkley et al., 2016). In the parent trial, there
was no overall effect of daily co‐trimoxazole prophylaxis on mortality
or growth (Berkley et al., 2016).
2.2 | Study setting
The trial recruited 1,778 children from paediatric wards of four hospi-
tals in Kenya from November 2009 to March 2014. Three of the four
hospitals were along the Kenyan coastline: Coast General Hospital in
Mombasa (a tertiary level hospital), Kilifi County Hospital and Malindi
sub‐county hospital, and Mbagathi sub‐county hospital in Nairobi,
predominantly serving a slum‐dwelling population. Coast General and
Mbagathi sub‐county hospitals were classified as urban hospitals
whereas Kilifi and Malindi county hospitals were classified as rural.
Inpatient management and referral of SAM cases to community‐
based therapeutic feeding programmes upon discharge followed the
Kenya national recommendations and World Health Organization
(WHO) guidelines (WHO, 2005). Children with signs of rickets were
treated with vitamin D (150,000 IU STAT intramuscular injection for
children younger than 6 months and 300,000 IU for children older than
6 months) and calcium supplements (Purecal/Calcimax® 50–75 mg/kg
per day for 3 months). The caregivers were advised to expose the
children to sunlight for at least 30 min per day. Children receiving
rickets treatment were reviewed after 2 weeks to ensure treatment
was continuing, as well as during the planned monthly study follow‐
up visits for the first 6 months, then bimonthly up to Month 12. If
rickets was unresolved or there was minimal improvement after
3 months, the doses were repeated.
2.3 | Study participants
All children admitted in the paediatric wards of the four hospitals
during the study period were screened for SAM, and those eligible
and consented were enrolled after completing the stabilization phase
of complicated SAM inpatient treatment (WHO, 2013). Children were
eligible for the trial if they had a negative HIV rapid‐antibody test, were
aged 2 to 59 months, and were hospitalized with complicated SAM
defined as mid‐upper arm circumference (MUAC) < 11.5 cm for
children 6 to 59 months old or MUAC < 11.0 cm for children 2 to
6 months or oedema at any age (Berkley et al., 2016).
2.4 | Outcomes
The main outcomes were episodes of life‐threatening events and
anthropometry (MUAC, weight, length/height, and head circumference)
during the course of the primary trial of 12 months. Life‐threatening
events were defined as all‐cause mortality or all hospital readmissions.
We also examined readmissions with severe pneumonia or diarrhoea
separately. Severe pneumonia was defined usingWHO 2015 guidelines
as presence of cough or breathing difficulty with either central cyanosis/
oxygen saturation < 90% or general danger signs (impaired conscious-
ness/lethargy/inability to breastfeed or drink) or severe respiratory
distress (chest indrawing/grunting;WHO, 2005). Diarrhoea was defined
as at least three episodes of loose/watery stools in 24 hr requiring
Key messages
• Clinically defined rickets was present among 12.9%
children with complicated severe acute malnutrition
mostly from urban areas in Kenya.
• Rickets at study enrolment was associated with
increased height gain, likely because of the calcium and
vitamin D treatment provided.
• Despite treatment, children with rickets at study
enrolment remained more susceptible to death and
hospital readmission with severe pneumonia compared
to children without rickets.
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hospitalization following WHO 2015 guidelines (WHO, 2005). Anthro-
pometric recovery was defined by changes from the baseline values of
absolute MUAC, and z scores for weight‐for‐height/length (WHZ),
weight‐for‐age (WAZ), height/length‐for‐age (HAZ), and head circum-
ference (HCZ) calculated using 2006 WHO growth references (WHO,
2011).
2.5 | Exposures
The main exposure of interest was clinically defined rickets at baseline,
which was systematically collected as present or not on the trial
baseline case report form. A clinical diagnosis of rickets was made by
trained study clinicians at study enrolment by the presence of swelling
of wrists and ankles, bowed legs, rachitic rosary, craniotabes, or
features of rickets on wrist X‐ray. Other baseline exposures examined
were age, gender, randomization arm, recruitment site, weight‐for‐
height, height‐for‐age, weight‐for‐age, head circumference‐for‐age z
scores, oedema, and admission diagnosis.
2.6 | Data sources/measurements
At the time of recruitment to the trial, child demographics, anthropom-
etry, and admission diagnosis were recorded on structured case report
forms. During each scheduled visit, anthropometry was performed,
and history of readmission to non‐study hospital or treatment as out-
patient was documented.
Children weight in kilograms were measured using an electronic
scale (Seca 825, Birmingham, UK). Infantometer (Seca 416, Birmingham,
UK) was used to measure length and stadiometer (Seca 215,
Birmingham, UK) to measure height in centimetres. Standard insertion
tape (TALC, St. Albans, UK) was used to measure MUAC in centimetres.
Free walk‐in clinics for unscheduled visits were provided at all the
study hospitals where minor illness was treated as outpatient, and
children with serious infections were admitted to study hospitals.
Readmission diagnosis and causes of deaths were documented by
trained study clinicians directly from study hospital records. For any
readmission to non‐study hospitals, admission diagnosis was extracted
from the hospital documents.
For community deaths, or those at non‐study hospitals where
deceased child medical records were not accessible, verbal autopsies
were undertaken. Causes of all deaths were assigned by two paediatri-
cians not involved in the trial using participant medical records or
verbal autopsies.
2.7 | Ethics
The Kenya National Ethical Review Committee (SSC 1562) and Oxford
Tropical Research Ethics Committee (reference number 18‐09)
approved the primary trial and this secondary analysis.
2.8 | Statistical methods
Children were stratified as either having diagnosis of clinical rickets or
not at baseline. To identify factors associated with rickets at baseline,
we used multivariable logistic regression analysis, retaining all the var-
iables examined in the univariable model. For analysis of all‐cause
mortality, we used single event survival analysis with time at risk
defined as the period from the date of enrolment in the study up to
the date of death, lost to follow‐up, withdrew, or completed study
follow‐up (Month 12). For readmissions to hospital, we performed
multiple event survival analysis, allowing participants to contribute
more than one event during the follow‐up. Time at risk was period
from time of enrolment to the trial to an episode of readmission or
death or lost to follow‐up or withdrew or completed study follow‐ups.
Time to any life‐threatening event (all‐cause mortality, all
readmissions, readmissions with severe pneumonia or diarrhoea) curves
were fitted using the Kaplan–Meier method and log‐rank test used to
compare distribution of events between children with and without
rickets at study enrolment. The effect of rickets on risk of the life‐
threatening events was estimated using Cox proportional regression
analysis and reported as hazard ratios (HR) and respective 95% confi-
dence intervals. We performed univariable analysis with the main expo-
sure (baseline rickets) as the only independent variable to yield the crude
HR and added a priori risk factors (baseline age, randomization arm, and
gender) plus factors associated with baseline rickets to obtain adjusted
HR. To test for effect modification, we compared models with and with-
out interaction terms using likelihood‐ratio tests.
To examine effects of rickets on growth, we used generalized
estimating equations (GEE) for regression models with exchangeable
correlation structure and the respective changes in monthly anthro-
pometry as the dependent variable. We constructed univariable GEE
regression models with baseline rickets as the only independent vari-
able to yield the crude regression coefficient. Then, in multivariable
GEE regression models, we adjusted for potential confounders: age,
gender, urban/rural site, and randomization arm.
For a sensitivity analysis, missing anthropometry from missed
visits, or where follow‐up was done at home and only MUAC was
taken, were imputed using the “linear interpolation” approach and used
in the GEE regression analysis. The method linearly interpolates a miss-
ing value by using values before and after the missing one (Engels &
Diehr, 2003). This way, we only imputed anthropometry for missed
follow‐up; for example, if a child had anthropometry measurement at
Visits 1 and 3, but missed anthropometry at Visit 2, Visits 1 and 3 mea-
surements were used to impute value for Visit 2.
No formal sample size estimation was done for this secondary
analysis because data from all the children enrolled in primary trial
were analysed. The primary trial enrolled 1,778 children, which was
adequate to detect one‐third mortality reduction from 15% among
the control group with a power of 90% assuming p < .05.
All statistical analysis was performed using STATA version 13.1
(STATACorp, College Station, TX, USA).
3 | RESULTS
3.1 | Participants
Of the 1,778 children recruited in the trial, 230 (12.9%, 95% CI [11.4,
14.6]) had clinical signs of rickets. The prevalence of rickets was higher
at urban than rural sites (15% vs. 4.7%, p < .001; Table S1). At Month 3
follow‐up assessment, 79/230 (34%) children still had signs of rickets.
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Children with rickets were younger than those without rickets: median
(interquartile range) age 9 (6 to 13) and 11 (7 to 17) months,
respectively (p = .002). Children with signs of rickets had lower MUAC,
WHZ, and HAZ than those without but had larger HCZ and a lower
prevalence of oedema (Table 1).
3.2 | Associations with rickets
Enrolment at an urban site, HAZ and HCZ were associated with rickets
(Table 2). Breastfeeding, known tuberculosis at enrolment, and an
index admission diagnosis of severe pneumonia were associated with
signs of rickets in the univariable analysis; however, these associations
attenuated in the multivariable analysis (Table 2).
3.3 | Rickets and mortality
There were 257/1,778 (15%) deaths during 1 year comprising 1518.3
child years of observation (CYO); 48/230 (21%) among children with
signs of rickets; and 209/1,548 (14%) among the children without rick-
ets, crude hazard ratio (HR) 1.59 (95% CI [1.16, 2.17]); Table 3 and
Figure 1A. After adjusting for potential confounders, rickets at study
enrolment was associated with mortality; adjusted HR 1.61 (95% CI
[1.14, 2.27]); Table 3. There was no evidence of effect modification
by age (p = .56), gender (p = .63), or site (p = .52).
3.4 | Rickets and hospital readmissions
There were 577 hospital readmissions among 425/1,778 (24%)
children (Table S2). Rates of readmission among children with and
without clinical rickets were 55 (95% CI [46, 67]) and 35 (95% CI [33,
39]) readmissions per 100 CYO. Having signs of rickets at study
enrolment was associated with risk of readmission after adjusting for
potential confounders, adjusted HR 1.37 (95% CI [1.09, 1.72]);
Figure 1b and Table 3. There was no evidence of effect modification
by age (p = .42), gender (p = .53), or site (p = .44).
3.5 | Rickets and severe pneumonia
In total, 392 readmissions with severe pneumonia were recorded dur-
ing the 1 year of follow‐up among 308/1,778 (17%) participants (Table
TABLE 1 Selected baseline characteristics of the study participants
Characteristica
Rickets status at baseline
Total (N = 1,778) No rickets (N = 1,548) Rickets (N = 230) p‐value
Demographics
Age in months
<6 months 305 (17.2) 264 (17.1) 41 (17.8) .002
6 to 11 months 679 (38.2) 573 (37.0) 106 (46.1)
12 to 23 months 595 (33.5) 523 (33.8) 72 (31.3)
≥24 months 199 (11.2) 188 (12.1) 11 (4.8)
Gender (female) 875 (49.2) 766 (49.5) 109 (47.4) .55
Urban hospitals 1356 (76.3) 1146 (74.0) 210 (91.3) <.001
Randomized to co‐trimoxazole prophylaxis 887 (49.9) 775 (50.1) 112 (48.7) .70
Nutritional status
Nutritional oedema 300 (16.9) 283 (18.3) 17 (7.4) <.001
Mid‐upper arm circumference (cm), mean ± SD 10.6 ± 1.1 10.6 ± 1.1 10.3 ± 1.0 <.001
Weight‐for‐height z score, mean ± SD −3.3 ± 1.3 −3.3 ± 1.3 −3.5 ± 1.3 .01
Weight‐for‐age z score, mean ± SD −4.0 ± 1.1 −3.9 ± 1.1 −4.3 ± 1.0 <.001
Length‐for‐age z score, mean ± SD −2.9 ± 1.7 −2.8 ± 1.6 −3.1 ± 1.7 .02
Head circumference‐for‐age z scoreb, mean ± SD −1.8 ± 1.4 −1.8 ± 1.4 −1.4 ± 1.4 .009
Haemoglobin (g/dl)c, mean ± SD 9.8 ± 2.2 9.7 ± 2.2 10.2 ± 2.2 .001
Signs of vitamin A deficiency 4 (0.2) 3 (0.2) 1 (0.4) .43
Breastfeeding 1092 (61.4) 918 (59.3) 174 (75.7) <.001
Admission diagnosis
Known tuberculosis at enrolment 67 (3.8) 50 (3.2) 17 (7.4) .002
Index admission for severe pneumonia 656 (36.9) 528 (34.1) 128 (55.7) <.001
Index admission for diarrhoea 1021 (57.4) 891 (57.6) 130 (56.5) .77
Treated for shock during index admission 184 (10.4) 154 (10.0) 30 (13.0) .15
Note. SD = standard deviation.
aValues presented are n (%) unless specified.
bData collected from April 2011 (N = 708).
cFifty‐two records missing (N = 1,726); blood samples were not collected; means were compared using z test and proportions using chi‐square test. Vitamin
A deficiency was detected using Bitot's spots, dry conjunctiva/cornea, corneal ulceration, or keratomalacia.
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S2). There were 83 and 309 episodes among children with and without
rickets; incidence rate of 44 (95% CI [35.3, 54.3]) and 23 (95% CI [20.8,
26.0]) severe pneumonia readmissions per 100 CYO, respectively.
After adjusting for potential confounders, rickets at study enrolment
was associated with risk of readmission with severe pneumonia
adjusted HR 1.37 (95% CI [1.05, 1.79]), Figure 1c and Table 3. There
was no evidence of effect modification by age (p = .51), gender
(p = .73), or site (p = .67).
3.6 | Rickets and severe diarrhoea
There were 243 readmissions for diarrhoea among 218/1,778 (12%)
children (Table S2). There were 41 and 202 episodes among children
with and without signs of rickets; incidence rate of 22 (95% CI [15.9,
29.4]); and 15 (95% CI [13.3, 17.5]) diarrhoea readmissions per 100
CYO, respectively. Rickets at study enrolment was not associated with
the risk of readmission with diarrhoea after adjusting for potential
confounders; adjusted HR 1.05 (95% CI [0.73, 1.51]); Figure 1d and
Table 3. There was no evidence of effect modification by age
(p = .55), gender (p = .78), or site (p = .34).
3.7 | Rickets and growth
Clinical signs of rickets at study enrolment were associated with
increased height growth; adjusted regression coefficient 0.19 (95%
CI [0.10, 0.28]); Table 4 and Figure S1. However, signs of rickets had
no effect on head circumference, MUAC, and weight growth (Table 4
and Figure S1).
Results were similar in a sensitivity analysis with imputation of
missing anthropometric data, where signs of rickets were associated
with increased height growth; adjusted regression coefficient 0.19
(95% CI [0.10, 0.28]), but not with head circumference, MUAC, or
weight gain (Tables S3 and S4).
TABLE 2 Univariable and multivariable analysis of factors associated with rickets at baseline
Characteristic
Univariable analysis Multivariable analysis
Crude odds ratios 95% CI p‐value Adjusted odds ratios 95% CI p‐value
Demographics
Age (months) 0.97 0.95, 0.99 .001 0.99 0.95, 1.03 .63
Gender (female) 0.92 0.70, 1.21 .55 0.59 0.37, 1.03 .05
Urban hospitals 3.68 2.30, 5.91 <.001 9.32 2.79, 31.13 <.001
Randomized to co‐trimoxazole prophylaxis 0.95 0.72, 1.25 .70 1.02 0.65, 1.58 .95
Nutritional status
Nutritional oedema 0.36 0.21, 0.59 <.001 0.84 0.32, 2.20 .73
Mid‐upper arm circumference (cm) 0.75 0.66, 0.85 <.001 0.87 0.66, 1.15 .32
Length‐for‐age z score 0.91 0.83, 0.99 .02 0.66 0.55, 0.80 <.001
Head circumference‐for‐age z scorea 1.22 1.05, 1.43 .009 1.53 1.24, 1.89 <.001
Haemoglobin (g/dl)b 1.10 1.04, 1.17 .001 1.09 0.97, 1.21 .14
Breastfeeding 2.13 1.55, 2.93 <.001 1.88 0.99, 3.55 .05
Admission diagnosis
Known tuberculosis at enrolment 2.39 1.35, 4.22 .003 1.24 0.37, 4.19 .73
Index admission for severe pneumonia 2.42 1.83, 3.21 <.001 1.31 0.79, 2.16 .30
Index admission for diarrhoea 0.96 0.72, 1.27 .77 0.83 0.50, 1.38 .48
Treated for shock during index admission 1.36 0.89, 2.06 .15 2.10 0.99, 3.97 .05
Note. CI = confidence interval.
aData collected from April 2011 (N = 708).
bFifty‐two records missing (N = 1,726) because blood samples were not taken.
TABLE 3 Univariable and multivariable analysis of events during follow‐up associated with rickets at study enrolment
Type of events
Univariable analysis Multivariable analysis
Crude hazard ratios 95% CI p‐value Adjusted hazard ratiosa 95% CI p‐value
Mortality 1.59 1.16, 2.17 .004 1.61 1.14, 2.27 .007
All hospital readmissions 1.55 1.25, 1.91 <.001 1.37 1.09, 1.72 .008
Severe pneumonia 1.87 1.47, 2.24 <.001 1.37 1.05, 1.79 .02
Diarrhoea 1.41 1.00, 1.97 .05 1.05 0.73, 1.51 .77
Note. CI = confidence interval.
aAdjusted for gender, age, co‐trimoxazole randomization arm, recruitment site, baseline absolute mid‐upper arm circumference, oedema, and height‐for‐age
z scores.
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4 | DISCUSSION
Clinical signs of rickets were common among Kenyan children who
were hospitalized with complicated SAM and of prognostic importance
for both mortality and for subsequent episodes of severe pneumonia
despite treatment with calcium and vitamin D. Rickets occurred
predominantly in urban sites and was associated with stunting. An
association with increased head circumference is likely to have been
due to the inclusion of craniotabes in the diagnostic criteria. However,
the clinical diagnosis of rickets in the absence of systematic measure-
ment of vitamin D, calcium, alkaline phosphatase, and their pathways
is necessarily subjective. In the parent trial, the individual signs used
to identify rickets were not collected; however, the young age of cases
(9 months) indicates that the classical presentation of bowed legs in
walking‐age children is not the predominant syndrome, as was also
demonstrated in an urban community setting in Nairobi (Jones et al.,
2017).
Clinical signs of rickets are suggestive of calcium and/or vitamin D
deficiency and have high sensitivity for these conditions (Thacher,
Fischer, & Pettifor, 2002). However, they may also reflect a diet
deficient in other micronutrients affecting both growth and immunity.
Evidence from other studies suggest that deficiency of vitamins A, D,
and E can occur concurrently and are associated with risk of respira-
tory tract infections (Zhang et al., 2016). Children with clinical signs
of rickets were more stunted and wasted; however, clinical rickets
was associated with risk of mortality and serious infections requiring
FIGURE 1 Kaplan–Meier curves for risk of (a) mortality, (b) all readmissions, (c) readmission for severe pneumonia, and (d) readmission for
diarrhoea stratified by rickets status at baseline. Blue dashed line = no rickets; red line = rickets
TABLE 4 Effects of baseline rickets on changes in anthropometry during 12 months follow‐up
Univariable analysis Multivariable analysis
Crude coefficient 95% CI p‐value Adjusted coefficienta 95% CI p‐value
Monthly change in HAZ 0.16 0.07, 0.24 .001 0.19 0.10, 0.28 <.001
Monthly change in HCAZ 0.02 −0.11, 0.14 .81 0.01 −0.12, 0.13 .93
Monthly change in WAZ 0.03 −0.09, 0.15 .60 0.05 −0.07, 0.17 .40
Monthly change in WHZ −0.12 −0.28, 0.04 .14 −0.10 −0.26, 0.05 .19
Monthly change in MUAC −0.09 −0.23, 0.05 .23 −0.05 −0.20, 0.09 .45
Note. HAZ = height‐for‐age z score; HCAZ = head circumference‐for‐age z score; WAZ = weight‐for‐age z score, WHZ = weight‐for‐height z score;
MUAC = mid‐upper arm circumference.
aAdjusted for gender, age, co‐trimoxazole randomization arm, and urban/rural hospital.
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hospitalization even after adjusting for these anthropometrics
measurements. Vitamin D plays a major role in modulating both innate
and adaptive immunity (Rosen et al., 2016).
We found that linear growth, but not markers of wasting, was
improved in children with signs of rickets at baseline, even after
adjustment for age. This was largely accounted for by a smaller decline
in height/length‐for‐age z score between baseline and Month 1 (Fig-
ure S1). The most likely explanation is that these children were treated
with calcium and vitamin D additional to that contained in therapeutic
milks and ready‐to‐use therapeutic food, and this promoted linear
growth. Previous studies have reported that vitamin D supplementation
increased height growth (Ganmaa et al., 2017). Another potential expla-
nation is regression to the mean; however, the fact that the height/
length‐for‐age z scores of children with and without rickets do not con-
verge (Figure S1) strongly suggests otherwise.
The prevalence of clinical rickets in our study agrees with that
from India (15.4%) and Ethiopia (10.5%) (Desyibelew, Fekadu, &
Woldie, 2017; Kumar, Singh, Joshi, Singh, & Bijesh, 2014). The finding
that clinically defined rickets was associated with baseline stunting and
wasting agrees with previous reports (H. L. Jones et al., 2015). In our
study, clinical rickets cases were predominantly from urban sites as
previously reported (Edwards et al., 2014; K. D. J. Jones et al., 2017).
Other studies, although not among children hospitalized with compli-
cated SAM, have found evidence of association between vitamin D
deficiency and severe pneumonia, gastrointestinal infection, and
growth (Ganmaa et al., 2017; Haider et al., 2010; Muhe et al., 1997;
Thornton et al., 2013). This partially concurs with our study findings;
however, in our population, diarrhoea risk was not associated with clin-
ical defined rickets.
There is inconclusive evidence from prior studies on the efficacy
of vitamin D supplementation in reducing all‐cause mortality, hospital
admissions, or incidence of severe pneumonia and diarrhoea (Das,
Singh, Panigrahi, & Naik, 2013; Yakoob et al., 2016). Our results sug-
gest that the treatment for rickets that we gave did not result in reduc-
tion in risks of mortality or of readmission to that of the other children
in the trial. We did not measure compliance with rickets treatment;
however, there is the possibility that the current rickets treatment
guidelines are not adequate to address all the macronutrient demands
for children recovering from SAM. Future studies should explore the
possibility of concurrent micronutrient deficiency and optimal treat-
ment among this population of children recovering from SAM. Such
research should involve screening for multiple macronutrient deficien-
cies and design of robust clinical trials to evaluate potential
interventions.
4.1 | Strengths and limitations
The main strength of the study was its prospective design that attained
a 95% follow‐up for 1 year and the well documented life‐threatening
events.
Themajor limitation was the use of clinical signs to diagnose rickets.
Although clinical signs are sensitive in identification of rickets cases, they
have poor specificity, and therefore, we could have missed some cases
especially among children with oedema that could blur the clinical signs
(Jones et al., 2017; Thacher et al., 2002), that is, many other childrenmay
have had low calcium or vitamin D, and this may have introduced bias.
Severe pneumonia and diarrhoea were defined using the WHO clinical
signs; although these signs are sensitive, they have low specificity.
However, this reflects the diagnostic criteria commonly used in such
poor‐resource settings and do not preclude the fact that children diag-
nosed with clinical signs of rickets had higher risks of life‐threatening
infections requiring hospital admission or causing death.
This being a secondary data analysis of a clinical trial, active fol-
low‐ups and the free walk‐in clinics offered could have led to over-
identification of serious infections leading to over‐reporting of
readmissions compared to children in the community. It is also possi-
ble, the non‐severe illness treated during the follow‐up visits could
have prevented them progressing to severe infection requiring read-
mission. Missing follow‐up anthropometry could have introduced bias,
but imputing missing data did not change our results significantly. Our
results should be interpreted cautiously because it is not generalizable
to children with uncomplicated SAM or complicated SAM infected
with HIV.
5 | CONCLUSION
Rickets is common among children with complicated SAM, predomi-
nantly from urban sites, and is associated with increased risk of death
and hospital admissions with severe pneumonia. Increased height
growth may have been due to the calcium and vitamin D treatment
provided. Future work should explore the possibility of other micronu-
trient deficiency and optimal treatment of rickets in this high‐risk
population.
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